Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04659382
Title Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (SIRTCI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Federation Francophone de Cancerologie Digestive
Indications

colorectal cancer

Therapies

Atezolizumab + Bevacizumab + Capecitabine + Oxaliplatin

Age Groups: senior | adult
Covered Countries FRA

Additional content available in CKB BOOST